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Abstract— Diffuse optical breast imaging utilizes near-infrared 
(NIR) light propagation through tissues to assess the optical 
properties of tissue for the identification of abnormal tissue. This 
optical imaging approach is sensitive, cost-effective, and does not 
involve any ionizing radiation. However, the image 
reconstruction of diffuse optical tomography (DOT) is a 
nonlinear inverse problem and suffers from severe ill-posedness, 
especially in the cases of strong noise and incomplete data. In this 
paper, a novel image reconstruction method is proposed for the 
detection of breast cancer. This method split the image 
reconstruction problem into the localization of abnormal tissues 
and quantification of absorption variations. The localization of 
abnormal tissues is performed based on a new well-posed 
optimization model, which can be solved via differential evolution 
optimization method to achieve a stable image reconstruction. 
The quantification of abnormal absorption variations is then 
determined in localized regions of relatively small extents, which 
are potentially tumors. Consequently, the number of unknown 
absorption variables can be greatly reduced to overcome the 
underdetermined nature of diffuse optical tomography (DOT), 
allowing for accurate and stable reconstruction of the abnormal 
absorption variations in the breast. Numerical simulation 
experiments show that the image reconstruction method is stable 
and accurate for the identification of abnormal tissues, and 
robust against measurement noise of data.  
Index Terms—Diffuse optical tomography (DOT), breast 
imaging, image reconstruction, differential evolution (DE).  
I. INTRODUCTION 
reast cancer is a major health problem. If this disease is 
treated at an early-stage using current therapies, patient 
prognosis will be improved significantly. Currently, multiple 
methods are available for breast cancer screening and 
diagnosis. The x-ray mammography is an effective screening 
technique. However, the breast consists of tissues with similar 
densities and has similar attenuation coefficients. The 
appearance of cancer on mammograms has a substantial 
similarity to that of normal tissues. The x-ray mammography  
is less sensitive in dense breast [1]. X-rays are also a type of 
ionizing radiation, which bears a risk of cancer induction. 
Magnetic Resonance Imaging (MRI) is another effective and 
sensitive technique to detect cancer in dense tissues. It has a 
very high negative predictive value, which helps distinguish 
benign tumors and malignant tumors, and decrease the 
possibility of false negative diagnosis. A major disadvantage 
of MRI is much more expensive and time-consuming than 
other breast-diagnostic methods. Ultrasonography (US) can 
delineate cysts, benign and malignant masses. But it is limited 
by poor soft tissue contrast, inherent speckle noise, and strong 
operator dependence [2]. The optical molecular imaging 
modality uses exogenous fluorescent probes as additional 
contrast agents that target molecules relevant to breast cancer 
[3]. The use of fluorescent probes has a potential in early 
breast cancer detection but the effectiveness of fluorescence 
imaging relies on the functions of the probes [4]. Molecular 
contrast probes on specific tumor receptors or tumor 
associated enzymes are also under development. 
Diffuse optical tomography (DOT) was introduced the early 
1990s. DOT uses near-infrared light transmission and intrinsic 
breast tissue contrast for the detection and characterization of 
abnormal tissue [5]. It is sensitive, cost-effective, and does not 
involve any ionizing radiation, and has a high sensitivity due 
to the rich optical absorption contrast.  Owing to the relatively 
low absorption of hemoglobin, water and lipid at wavelengths 
of 650–1000 nm, near-infrared (NIR) light can transmit 
through several centimeters of biological tissue with an 
adequate signal-to-noise ratio for breast tomographic imaging 
[6]. Furthermore, in this spectral range, oxy-hemoglobin and 
deoxy-hemoglobin and lipids predominantly affect the 
absorptive properties of the breast tissue. There is a difference 
in total hemoglobin concentration levels between benign and 
malignant breast lesions, so it was a useful indicator for 
distinguishing between benign and malignant breast lesions 
[7]. By combining images reconstructed by DOT at various 
wavelengths, concentrations of oxy- and deoxy hemoglobin, 
and water can be determined to reveal tumors from 
background tissue [8].  
However, NIR light is strong scattering in biological 
tissues, the measurable quantity can only be collected on a 
partial external surface of an object, and light fields obtained 
from different excitation sources are highly correlated. The 
resultant volumetric reconstruction is a nonlinear inverse 
problem and suffers from severe ill-posedness exaggerated by 
data noise and measurement incompleteness. The efficient, 
stable, and accurate image reconstruction is the most 
challenging imaging tasks. The Born and Rytov 
approximation are popular linearization methods [9], which 
simplify the inverse problem as a linear system to describe the 
relationship between tissue absorption coefficients and 
boundary measurement. The regularization or stabilization 
techniques are applied to obtain physically realistic results.  In 
the case of sparse distribution of optical parameters, the total 
variation (TV) regularization [10] is more efficient than 
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generic regularization. Sparse image reconstruction with the l1 
norm regularization is also helpful to achieve a stable image 
recovery from incomplete and inaccurate measurements [11, 
12]. However, these methods cannot fundamentally solve the 
ill-posed problem of the diffuse optical tomography, usually 
resulting in aberrant image reconstruction in the presence of 
measurement noise.  
In this paper, we propose a new diffuse optical tomographic 
imaging method for the detection of breast cancer. This 
method divides the image reconstruction problem into the 
localization of abnormal tissues and the quantification of 
absorption variations. The localization of abnormal tissues is 
performed based on a well-posed optimization model, which 
can be solved using differential evolution global optimization 
method. The quantification of abnormal absorption variations 
is then determined in localized regions of relatively small 
extents, which are potentially tumors. This method is robust 
against measurement noise of data, and produces accurate and 
stable image reconstruction of abnormal absorption variations 
in the breast. 
II. IMAGE RECONSTRUCTION 
A. Imaging system design 
The optical breast imaging system consists of an array of 
photon detectors, a light source plate, and system frame. An 
array (64×64) of avalanche photodiode (APD C12402-04, 
Hamamatsu) is assembled into a 2D detector array to measure 
optical signals [13]. APD has excellent photon-counting 
capability for detecting extremely weak light at the photon 
counting level, a fine time resolution, and a wide spectral 
response range. Sixty-four optical fibers are arranged into 8 
rows by 8 columns, and mounted on the transparent plate. The 
breast can be slightly compressed between the two parallel 
glass plates.  A NIR laser (725nm-875nm) is connected with a 
fiber channel to excite the breast. The light source and 
detectors are placed on the opposite sides of the breast, as 
shown in Figure 1. The source and detectors can be rotated to 
change the excitation-detection arrangement for sufficient 
signal acquisition. During an optical scanning, the breast is 
sequentially illuminated by switching the near-infrared laser to 
different fiber channels. Light signals emanating from the 
breast is measured by the detectors for each source position. 
The measured dataset for every source-detector pair is used for 
image reconstruction of absorption variations. The system is 
calibrated and optimized for high-performance imaging. The 
imaging system can also be adapted to time-
resolved/frequency domain imaging mode. 
B.  Physical model 
Optical imaging utilizes light propagating through tissue for 
assessment of optical properties. The propagation of light in 
biological tissues is a complex process involving both 
absorption and scattering of light. The light propagation model 
describes the interaction of photons with tissues and predicts a 
light intensity distribution in the breast and on its external 
surface. By minimizing the discrepancy between the predicted 
data and measured data, an image reconstruction algorithm 
can recover the spatial distribution of intrinsic optical tissue 
properties. The radiative transfer equation (RTE) accurately 
models the photon propagation in biological tissues [14, 15]. 
Due to the extensive computational cost, it is difficult to 
directly apply RTE for biomedical tomographic imaging. The 
diffusion approximation (DA) model to RTE is widely used to 
describe the NIR light transport in biological tissues with an 
adequate accuracy in strongly scattering and weakly absorbing 
objects, and a high computational efficiency [14]. The steady-
state DA model is expressed as follows: 
          ,aD S       r r r r r r       (1) 
where r  is a positional vector,  r  is the NIR photon 
fluence rate,   rS  is the NIR source,  ra  is the absorption 
coefficient,  rD  is the diffusion coefficient defined by 
       rrr saD   3 ,  rs  is the reduced scattering 
coefficient, and 3R  a region of interest (ROI) in the 
object. If no photon travels across the boundary   into the 
tissue domain Ω, DA is constrained by the Robin boundary 
condition [16]: 
        rrrr ,02 D ,      (2)                                        
where   is an outward unit normal vector on  , and   the 
boundary mismatch factor between the tissue with a refractive 
index n  and air, which can be approximated by 
     11  with nnn 06.067.071.044.1 12    
[16]. The measurable photon fluence on the surface of the 
object can be expressed as, 
        rrνrr ,Dm .               (3)                                           
Breast tissue consists mainly of light elements with low 
atomic numbers, and its elemental composition is nearly 
uniform with little density variation. Hence, the spatial 
variation of scattering coefficients in breast tissues is slow 
[11]. Hence, in this context, we only focus on the absorption 
 
. Figure 1. Schematic diagram of breast optical imaging system 
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contrast since angiogenesis in cancer mainly causes a change 
in absorption properties of hemoglobin. Accordingly, we can 
decompose the absorption coefficients into
     rrr aaa  
0 , where  r0a  is the absorption 
coefficient of normal breast tissue, and  ra  denotes the 
abnormal absorption variations in tissues, since malignant 
tissues show higher levels of absorption compared to healthy 
tissues. Hence, we can rewrite Eq. (1) as follows: 
                rrrrrrrr ,0 SD aa    (4)                      
Eq. (4) is the governing imaging model for the image 
reconstruction of abnormal tissues. 
C.  Localization of abnormal absorptions 
The geometrical shape of the compressive breast can be 
accurately established via laser scanning 
(http://www.nextengine.com). From the geometrical shape of 
the compressive breast, a finite-element mesh is generated 
using the computer graphic techniques (Amira software). Key 
reference points are marked on breast. Accordingly, the 
markers also appear on the measured photon density image. 
Thus, the one-to-one relationship between all pixels on the 
measured photon density image and the coordinates of the 
finite elements model can be established for the image 
registration. Based on finite element model, differential 
equations (2) and (4) can be discretized into a matrix equation 
with respect to the photon fluence rate  r  [17],  
  AΦ B δ Φ S ,                                (5) 
where  1 2, , , N  δ is the vector of nodal abnormal 
absorption variations  ra , and the components of the 
matrix A  is computed as 
           
    ,,,2,1,,d2
dd 0
Nji
Da
ji
jiajiij






rrr
rrrrrrrr


        (6) 
and the components of the matrix B  is computed as 
     
1
d , , 1, 2, ,
N
ij k k i j
k
b i j N   
 
   r r r r ,            (7)                          
where    Nii ,,2,1 r  are the shape functions. Since the 
matrices A and B in Eq. (5) are positive definite, we have 
  
1
 Φ A B δ S .                                 (8) 
To simplify the computational complexity, Eq. (8) can be 
linearized to establish the linear relation between the measured 
photon fluence rate  Φ and abnormal absorption variations 
δ ,   
       1    0 0Φ Φ A B Φ δ ,                   (9) 
where   is a boundary nodal set on the finite element mesh 
corresponding to the measurable photon fluence rates on upper 
surface and lower surface of the breast, SAΦ 10
  is the 
photon fluence rate without absorption perturbation. To find a 
stable solution of Eq. (9), we introduce the following 
optimization model,  
        
 
* * 1
1 2
[ , ] arg min
0, 1,2, ,
0, , , ,
k
k
i k
i
j n
p
k n
j i i i



      


 

 

0 0A B Φ δ Φ Φ
,     (10) 
where the vector δ only includes n positive nonzero values
 
niii
 ,,,
21
 , which represents the abnormal absorption 
variations at isolated locations determined by the 
corresponding nodal indices  1 2, , , np p p , and n is a known 
positive integer which can be estimated as prior knowledge. 
For breast imaging, n represents the number of tumors in the 
breast. Generally it is reasonable to assume that n is less than 3 
for the early stage breast tumor detection, helping to achieve a 
high computational efficiency of the optimization model (10). 
Each nodal index  1, 2, ,kp k n  corresponds to the central 
position of a tumor in the breast.  
Eq. (10) are a NP (nondeterministic polynomial time) 
problem and cannot be efficiently solved using a popular 
gradient-based optimization method. Hence, a differential 
evolution (DE)-based heuristic reconstruction algorithm can 
be used to solve the optimization problem. DE is a powerful 
stochastic global optimization strategy, which regenerates a 
population through executing some simple arithmetic 
operations such as mutation, crossover and selection, which 
has demonstrated a superior converging behavior and a high 
precision. This DE method is very efficient especially for the 
small number n of variables. In case of the unknown n, we can 
also heuristically determine the number of tumors by 
gradually increasing the number of positive variations and 
solve the optimization problem in Eq. (10). For each 
reconstructed image, if two or more positive abnormal 
absorption variations are so close that they cannot be isolated 
within a user-provided spatial resolution, they should be 
combined into single abnormal absorption variations. 
Generally speaking, the number of tumors can be iteratively 
and heuristically determined to interpret measured data 
effectively.  
D. Quantification of absorption variations 
Based on central locations of tumors estimated by the 
reconstruction algorithm in above subsection, we can further 
quantify the intensity distribution of abnormal absorption 
variations for all the tumors. We set a sub-region 
 nkk ,,2,1   around the tumor central position with a 
radius related to the estimation of the abnormal absorption 
variations  nk
ki
,,2,1*   to form a feasible region 
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
n
k
k
1
 of abnormal absorption variations for image 
reconstruction. From the feasible region  , we perform 
image reconstruction using an algorithm for sparse equations 
and least squares (LSQR) [17, 18] based on Eq. (10) as 
follows: 
        * 1argmin
,
      

 
0 0δ A B Φ δ Φ Φ
δ
        (11)                 
Using this methodology, the number of unknown variables is 
significantly reduced, and the image reconstruction of 
abnormal absorption variations in breast tissues can be 
performed effectively.  
III. NUMERICAL SIMULATION 
To quantify the performance of proposed image 
reconstruction method, a digital breast phantom is applied for 
the numerical experiments. The breast phantom is developed 
from clinical dual-energy x-ray CT [20] 
(http://mcx.sourceforge.net/cgi-bin/index.cgi?DigiBreast). 
Two tetrahedral meshs, a finer one with 65196 tetrahedral 
elements and 14490 nodes for solving the optical forward 
model, and coarser one with 22799 tetrahedral elements and 
4732 nodes for solving the inverse problem, are generated 
from the phantom. The phantom includes two different tumors 
in the shape of a 3D Gaussian-sphere to be expressed as 
   2 20exp 2T  r r - r , their centers of two tumors are 
respectively set to  188, 41,150r  and  140, 49,150r , and 
the standard deviation of the Gaussian sphere is 
  1.7661 mm  . The simulations utilizes 20 continuous wave 
(CW) sources at 690 nm and 830 nm, 2622 CW detectors at 
upper surface, and 2473 CW detectors at lower surface. The 
absorption between 700nm-800nm is dominated by deoxy-
hemoglobin while that between 800nm-900nm is dominated 
by oxy-hemoglobin, helping to recover the concentrations of 
deoxy- and oxy-hemoglobin.  
Table 1: Optical parameters 
Tissue type CHbO2 CHb 
μsʹ 
 690nm 830nm 
Adipose 13.84 4.81 0.851 0.713 
Fibroglandular 18.96 6.47 0.925 0.775 
Malignant 20.60 6.72 0.957 0.801 
 
The fibroglandular tissue volume fraction map  fC r  is 
obtained from digital mammogram. In the phantom 
experiments, it is assumed that the primary breast tissue 
constituents are fibroglandular and adipose tissue, and the 
optical properties can be estimated by  
     f fib a adir C r C r                      (12) 
The optical coefficients of adi  and fib  are determined from 
adipose and fibroglandular optical properties, respectively, 
based on the data in Table 1 [21].  aC r  is the adipose tissue 
volume fraction at location r , which can be computed by 
 1 fC r . The optical properties in the region of the tumor is 
estimated by 
         
    
1 t f fib a adi
t adi m adi
r C r C r C r
C r
  
   
  
  
              (13) 
where m  is the optical coefficient of malignant tumor 
computed from the data in Table 1, and   expresses the tumor 
optical contrast [20] (here,  is set to 2). 
A diffusion-equation based forward model was used to 
generate simulated CW optical measurements at 830 nm under 
various tumor settings. The diffusion equation was 
numerically solved on the forward mesh using the finite-
element method. For each forward simulation, we added 5% 
Gaussian noise to the model output to simulate realistic 
measurement noise. 
The image reconstruction algorithm in above Section was 
applied to identify the abnormal absorption regions from the 
generated simulated CW optical measurements data. Firstly, 
the central positions of two tumors were reconstructed at 
(188.35, 40.52, 14.31) and (139.18, 47.61, 15.29) based on 
optimization model (10).  Then the quantification estimation 
of absorption perturbation was performed based optimization 
model (11) and the resultant relative errors in terms of 
absorption distribution were about 15%.  We also conducted 
the image reconstruction with a compressive sensing (CS) 
regularization method to recovery the abnormal absorption 
variations from same dataset [17, 20]. These results show that 
the proposed method achieve accurate and stable image 
reconstruction clearly superior to the state of the art CS-based 
regularization reconstruction method [16, 21, 22], as shown in 
Fig. 3 (a-b). 
      
      
Figure 2. Breast phantom. (a) The 3D finite-element model 
with abnormal absorbing distribution, and (b) the true 2D 
slice of (a) at height=15 mm. 
(b) 
(a) 
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Figure 3. Reconstruction of abnormal tissues. (a) The 
reconstructed 2D slice corresponding to the slice in Fig. 
2(b) using the proposed method, and (b) the corresponding 
2D slice reconstructed using compressive sensing (CS)-
based regularization reconstruction method. 
IV. DISCUSSIONS AND CONCLUSION 
We have proposed a new optical tomographic imaging 
method for the detection of breast cancer. This method split 
the image reconstruction problem into the localization of 
abnormal tissues and quantification of absorption variations. 
The localization of abnormal tissues is performed based on a 
new well-posed optimization model, which can be solved via 
differential evolution optimization method to achieve a stable 
image reconstruction. For the early stage cancer detection, it is 
neither correct nor efficient to assume too many tumors. As far 
as the detection of a few numbers of tumors in a breast is 
concerned, the proposed image reconstruction method is very 
efficient to solve the optimization model of Eq. (10) for the 
determination of tumor central positions. Around the 
determined central positions of tumors, the quantification of 
abnormal absorption variations is then determined in localized 
regions of relatively small extents. Consequently, the number 
of unknown absorption variables can be greatly reduced to 
overcome the underdetermined nature of diffuse optical 
tomography, allowing for accurate and stable reconstruction of 
the abnormal absorption variations in the breast. The 
numerical simulations based on the realistic digital breast 
phantom have been performed to verify the feasibility of this 
method. The proposed method provides a practical and 
noninvasive tool for enhancing the accuracy of tumor 
diagnostics. 
Our forward model is based on continuous wave (CW) 
excitation, which provide high signal-to-noise ratio of 
measured photon fluence rate. The proposed method can be 
directly extended to time-resolved/frequency-domain optical 
tomography, which provides more measurement information 
to enhance stability of image reconstruction. This proposed 
reconstruction method is based on the diffuse approximation 
model for high computational efficiency, which works well in 
breast tissues with weakly absorbing and highly scattering. It 
is also straightforward to extend our method to more accurate 
photon transport models, such as radiative transport equation 
(RTE) [14], phase approximation [15], or Monte Carlo 
simulation [22]. At same time, the graphic processing unit 
(GPU) can be used to achieve high performance computing to 
accelerate the computation of the photon transport models.   
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